Screener
Tarsus Pharmaceuticals, Inc. TARS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s net margin?
- Tarsus Pharmaceuticals, Inc. (TARS) reported net margin of -7.7% in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s net margin changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s net margin increased by 75.4% year-over-year, from -31.1% to -7.7%.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s net margin?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s net margin has grown at a -11.7% compound annual growth rate (CAGR), from -24.2% to -14.7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude